S215: GEMSTONE-201: PRE-PLANNED PRIMARY ANALYSIS OF A MULTICENTER, SINGLE-ARM, PHASE 2 STUDY OF SUGEMALIMAB IN PATIENTS WITH RELAPSED OR REFRACTORY EXTRANODAL NATURAL KILLER/T CELL LYMPHOMA (R/R ENKTL). (23rd June 2022) - Huang, H.; Tao, R.; Yang, Y.; Cen, H.; Zhou, H.; Guo, Y.; Zou, L; Cao, J.; Huang, Y.; Jin, J.; Zhang, L.; Yang, H.; et al.